BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 15994942)

  • 21. Characterization of a neurotrophin signaling mechanism that mediates neuron survival in a temporally specific pattern.
    Shalizi A; Lehtinen M; Gaudilliere B; Donovan N; Han J; Konishi Y; Bonni A
    J Neurosci; 2003 Aug; 23(19):7326-36. PubMed ID: 12917366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response.
    Friedrich C; Shalaby T; Oehler C; Pruschy M; Seifert B; Picard D; Remke M; Warmuth-Metz M; Kortmann RD; Rutkowski S; Grotzer MA; von Bueren AO
    Childs Nerv Syst; 2017 Sep; 33(9):1463-1471. PubMed ID: 28695340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of Na+/H+ exchange in regulation of p38 mitogen-activated protein kinase activity and cell death after chemical anoxia in NIH3T3 fibroblasts.
    Rentsch ML; Ossum CG; Hoffmann EK; Pedersen SF
    Pflugers Arch; 2007 Jul; 454(4):649-62. PubMed ID: 17334779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ubiquitin-dependent regulation of MEKK2/3-MEK5-ERK5 signaling module by XIAP and cIAP1.
    Takeda AN; Oberoi-Khanuja TK; Glatz G; Schulenburg K; Scholz RP; Carpy A; Macek B; Remenyi A; Rajalingam K
    EMBO J; 2014 Aug; 33(16):1784-801. PubMed ID: 24975362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif.
    Barsyte-Lovejoy D; Galanis A; Clancy A; Sharrocks AD
    Biochem J; 2004 Aug; 381(Pt 3):693-9. PubMed ID: 15132737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
    Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
    Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of vertebrate myotome development by the p38 MAP kinase-MEF2 signaling pathway.
    de Angelis L; Zhao J; Andreucci JJ; Olson EN; Cossu G; McDermott JC
    Dev Biol; 2005 Jul; 283(1):171-9. PubMed ID: 15890335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, chaperoning, and metabolism of proteins are regulated by NT-3/TrkC signaling in the medulloblastoma cell line DAOY.
    Gruber-Olipitz M; Ströbel T; Chen WQ; Grotzer MA; Quehenberger F; Slavc I; Lubec G
    J Proteome Res; 2008 May; 7(5):1932-44. PubMed ID: 18336001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DUSP6/MKP-3 inactivates ERK1/2 but fails to bind and inactivate ERK5.
    Arkell RS; Dickinson RJ; Squires M; Hayat S; Keyse SM; Cook SJ
    Cell Signal; 2008 May; 20(5):836-43. PubMed ID: 18280112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
    Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
    J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C.
    Kato Y; Kravchenko VV; Tapping RI; Han J; Ulevitch RJ; Lee JD
    EMBO J; 1997 Dec; 16(23):7054-66. PubMed ID: 9384584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basic fibroblast growth factor promotes glial cell-derived neurotrophic factor gene expression mediated by activation of ERK5 in rat C6 glioma cells.
    Obara Y; Nemoto W; Kohno S; Murata T; Kaneda N; Nakahata N
    Cell Signal; 2011 Apr; 23(4):666-72. PubMed ID: 21130871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional regulation of tissue-specific genes by the ERK5 mitogen-activated protein kinase.
    Sohn SJ; Li D; Lee LK; Winoto A
    Mol Cell Biol; 2005 Oct; 25(19):8553-66. PubMed ID: 16166637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dominant negative FTase (DNFTalpha) inhibits ERK5, MEF2C and CREB activation in adipogenesis.
    Sharma G; Goalstone ML
    Mol Cell Endocrinol; 2005 Dec; 245(1-2):93-104. PubMed ID: 16356629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA damage induced apoptosis suppressor (DDIAS) is upregulated via ERK5/MEF2B signaling and promotes β-catenin-mediated invasion.
    Im JY; Yoon SH; Kim BK; Ban HS; Won KJ; Chung KS; Jung KE; Won M
    Biochim Biophys Acta; 2016 Nov; 1859(11):1449-1458. PubMed ID: 27412911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60.
    Kikuchi H; Yuan B; Yuhara E; Takagi N; Toyoda H
    Int J Oncol; 2013 Dec; 43(6):2046-56. PubMed ID: 24064676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop.
    Yan C; Ding B; Shishido T; Woo CH; Itoh S; Jeon KI; Liu W; Xu H; McClain C; Molina CA; Blaxall BC; Abe J
    Circ Res; 2007 Mar; 100(4):510-9. PubMed ID: 17272811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells: potential role in cell survival following oxidative insults.
    Suzaki Y; Yoshizumi M; Kagami S; Koyama AH; Taketani Y; Houchi H; Tsuchiya K; Takeda E; Tamaki T
    J Biol Chem; 2002 Mar; 277(11):9614-21. PubMed ID: 11782488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ERK5 promotes Src-induced podosome formation by limiting Rho activation.
    Schramp M; Ying O; Kim TY; Martin GS
    J Cell Biol; 2008 Jun; 181(7):1195-210. PubMed ID: 18573916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.